Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.

Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK.

Nanomedicine. 2019 Oct;21:102055. doi: 10.1016/j.nano.2019.102055. Epub 2019 Jul 15.

PMID:
31319179
2.

Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.

Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK.

J Pharmacol Exp Ther. 2019 Sep;370(3):855-863. doi: 10.1124/jpet.118.252809. Epub 2018 Oct 25.

PMID:
30361239
3.

The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Wafa EI, Geary SM, Goodman JT, Narasimhan B, Salem AK.

Acta Biomater. 2017 Mar 1;50:417-427. doi: 10.1016/j.actbio.2017.01.005. Epub 2017 Jan 4.

4.

Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines.

de Barros CM, Wafa EI, Chitphet K, Ahmed K, Geary SM, Salem AK.

Methods Mol Biol. 2017;1494:201-213.

PMID:
27718195

Supplemental Content

Support Center